Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.

Dr. Barry Dworkin

Medical Mythbusting Commentary for February 15, 2021

Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older. Play Now | Play in Popup | Download

Source:
Israeli Study Finds 94% Drop in Symptomatic COVID-19 Cases With Pfizer Vaccine

Related posts:

  1. Israeli real-world Pfizer vaccine study reports infection rates dropped by 33% in treatment group of 200K people >60 y.o vs 200K controls after 21 days, less than predicted by proponents of delaying 2nd dose. Stay on schedule until proven otherwise.
  2. Study: Hardened arteries in half of people aged 40-54. Yeah, so?
  3. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  4. Low risk perception among under-20’s in Ontario likely contributing to increasing COVID-19 cases in this age group. Before you criticize, if older individuals did not see their group affected, similar result would ensue. Classic risk perception psychology at work.
Bitnami